Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

09.08.2021

1 Acad Emerg Med
1 AJR Am J Roentgenol
3 Am J Obstet Gynecol
1 Am J Respir Crit Care Med
3 Ann Intern Med
9 BMJ
2 Clin Chem
10 Clin Infect Dis
3 Emerg Infect Dis
1 Eur J Radiol
1 Graefes Arch Clin Exp Ophthalmol
13 Infect Control Hosp Epidemiol
10 Int J Infect Dis
1 Intensive Care Med
6 J Infect
8 J Med Virol
3 J Travel Med
1 JAMA
9 Lancet
5 Lancet Infect Dis
2 MMWR Morb Mortal Wkly Rep
6 N Engl J Med
16 Nature
1 Radiology
3 Science



    Acad Emerg Med

  1. KALTISO SO, Seitz RM, Zdradzinski MJ, Moran TP, et al
    The impact of racism on emergency health care workers.
    Acad Emerg Med. 2021 Aug 6. doi: 10.1111/acem.14347.
    >> Share


    AJR Am J Roentgenol

  2. HAMMER MM
    Real-World Diagnostic Performance of RSNA Consensus Reporting Guidelines for Findings Related to COVID-19 on Chest CT.
    AJR Am J Roentgenol. 2021 Aug 4. doi: 10.2214/AJR.21.26560.
    >> Share


    Am J Obstet Gynecol

  3. SUN H
    Adjustment is Required to Calculate the Risk of Early Pregnancy Loss with Covid-19 Infection or Vaccination.
    Am J Obstet Gynecol. 2021 Aug 3. pii: S0002-9378(21)00861.
    >> Share

  4. SCHWARTZ A, Nir O, Toussia-Cohen S, Leibovich L, et al
    Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2mRNA vaccine.
    Am J Obstet Gynecol. 2021 Aug 2. pii: S0002-9378(21)00831.
    >> Share

  5. PACHECO LD, Berry M, Saad AF, Yates SG, et al
    Coagulation assessment with viscoelastic testing in asymptomatic post-partum patients with SARS-CoV-2 infection: a pilot study.
    Am J Obstet Gynecol. 2021 Jul 28. pii: S0002-9378(21)00826.
    >> Share


    Am J Respir Crit Care Med

  6. CARLOS WG, Gross JE, Cruz CD, Jamil S, et al
    Monoclonal Antibodies: Medical Uses for the Prevention and Treatment of Disease.
    Am J Respir Crit Care Med. 2021;203:P26-P27.
    >> Share


    Ann Intern Med

  7. AGARWAL A, Lang E
    In adults hospitalized with COVID-19, the 5-variable SOARS score predicted in-hospital mortality.
    Ann Intern Med. 2021 Aug 3. doi: 10.7326/ACPJ202108170.
    >> Share

  8. CLIFT AK, Saatci D, Coupland CAC, Dambha-Miller H, et al
    Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study.
    Ann Intern Med. 2021 Jul 20. doi: 10.7326/M21-1375.
    >> Share

  9. CHAGLA Z
    In patients with COVID-19, viral shedding time is 17 d and varies in some subgroups.
    Ann Intern Med. 2021 Aug 3. doi: 10.7326/ACPJ202108170.
    >> Share


    BMJ

  10. TAYLOR L
    Covid-19: WHO calls for booster shot ban until end of September.
    BMJ. 2021;374:n1962.
    >> Share

  11. MAHASE E
    Covid-19: All 16 and 17 year olds in the UK to be offered first vaccine dose.
    BMJ. 2021;374:n1958.
    >> Share

  12. MAHASE E
    Covid-19: CPAP reduces need for invasive mechanical ventilation in patients requiring oxygen, study finds.
    BMJ. 2021;374:n1950.
    >> Share

  13. MAHASE E
    Covid-19: Pfizer vaccine's efficacy declined from 96% to 84% four months after second dose, company reports.
    BMJ. 2021;374:n1920.
    >> Share

  14. DYER O
    Covid-19: Delta infections threaten herd immunity vaccine strategy.
    BMJ. 2021;374:n1933.
    >> Share

  15. O'DOWD A
    Covid 19: Most patients in England received good or excellent care in hospital, finds analysis.
    BMJ. 2021;374:n1935.
    >> Share

  16. BAMJI AN
    Infection with SARS-CoV-2 is not the same as covid-19.
    BMJ. 2021;374:n1896.
    >> Share

  17. ERFANI P, Binagwaho A, Jalloh MJ, Yunus M, et al
    Intellectual property waiver for covid-19 vaccines will advance global health equity.
    BMJ. 2021;374:n1837.
    >> Share

  18. MAHASE E
    Covid-19: Most symptomatic children recover within a week, study finds.
    BMJ. 2021;374:n1947.
    >> Share


    Clin Chem

  19. CAO J, Liu X, Muthukumar A, Gagan J, et al
    Poor Humoral Response in Solid Organ Transplant Recipients following Complete mRNA SARS-CoV-2 Vaccination.
    Clin Chem. 2021 Aug 6. pii: 6343450. doi: 10.1093.
    >> Share

  20. ZHANG Y, Ong CM, Yun C, Mo W, et al
    Diagnostic Value of Nucleocapsid Protein in Blood for SARS-CoV-2 Infection.
    Clin Chem. 2021 Aug 6. pii: 6343449. doi: 10.1093.
    >> Share


    Clin Infect Dis

  21. LI P, Ikram A, Peppelenbosch MP, Ma Z, et al
    Systematically Mapping Clinical Features of Infections With Classical Endemic Human Coronaviruses.
    Clin Infect Dis. 2021;73:554-555.
    >> Share

  22. CASADEVALL A, Joyner MJ, Pirofski LA
    Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy.
    Clin Infect Dis. 2021;73:e540-e542.
    >> Share

  23. BIGGERSTAFF M, Slayton RB, Johansson MA, Butler JC, et al
    Improving Pandemic Response: Employing Mathematical Modeling to Confront COVID-19.
    Clin Infect Dis. 2021 Aug 3. pii: 6338173. doi: 10.1093.
    >> Share

  24. XIANG F, Sun J, Chen PH, Han P, et al
    Early Elevation of Fibrosis-4 Liver Fibrosis Score Is Associated With Adverse Outcomes Among Patients With Coronavirus Disease 2019.
    Clin Infect Dis. 2021;73:e594-e601.
    >> Share

  25. FOURATI S, Bailly B, Le Bouter A, Guilpain L, et al
    Differential anti-S antibody titers in vaccinated residents during an outbreak of SARS-CoV-2 variant B.1.351 (beta) in an elderly nursing home.
    Clin Infect Dis. 2021 Aug 3. pii: 6338175. doi: 10.1093.
    >> Share

  26. LAWANDI A, Warner S, Sun J, Demirkale CY, et al
    Suspected SARS-CoV-2 Reinfections: Incidence, Predictors, and Healthcare Use among Patients at 238 U.S. Healthcare Facilities, June 1, 2020- February 28, 2021.
    Clin Infect Dis. 2021 Aug 5. pii: 6342166. doi: 10.1093.
    >> Share

  27. PADHI S, Pati A, Panda AK
    Effect of ivermectin in the treatment of COVID-19: A trial sequential analysis highlighted the requirement of additional randomized controlled trials.
    Clin Infect Dis. 2021 Aug 6. pii: 6343157. doi: 10.1093.
    >> Share

  28. COLEMAN KK, Tay DJW, Sen Tan K, Ong SWX, et al
    Viral Load of SARS-CoV-2 in Respiratory Aerosols Emitted by COVID-19 Patients while Breathing, Talking, and Singing.
    Clin Infect Dis. 2021 Aug 6. pii: 6343417. doi: 10.1093.
    >> Share

  29. BANNO M, Tsujimoto Y, Ishikane M
    Need for more randomized controlled trials with rigorous methodology to confirm that ivermectin is not a viable option for the treatment of coronavirus disease.
    Clin Infect Dis. 2021 Aug 6. pii: 6343415. doi: 10.1093.
    >> Share

  30. TENFORDE MW, Patel MM, Ginde AA, Douin DJ, et al
    Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.
    Clin Infect Dis. 2021 Aug 6. pii: 6343399. doi: 10.1093.
    >> Share


    Emerg Infect Dis

  31. TRUFFOT A, Andreani J, Le Marechal M, Caporossi A, et al
    SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy.
    Emerg Infect Dis. 2021;27.
    >> Share

  32. BADR DA, Picone O, Bevilacqua E, Carlin A, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 and Pregnancy Outcomes According to Gestational Age at Time of Infection.
    Emerg Infect Dis. 2021;27.
    >> Share

  33. SHUKLA BS, Warde PR, Knott E, Arenas S, et al
    Bloodstream Infection Risk, Incidence, and Deaths for Hospitalized Patients during Coronavirus Disease Pandemic.
    Emerg Infect Dis. 2021;27.
    >> Share


    Eur J Radiol

  34. VAN HEUSDEN HC, Swartz JE, Chargi N, de Jong PA, et al
    Feasibility of assessment of skeletal muscle mass on a single cross-sectional image at the level of the fourth thoracic vertebra.
    Eur J Radiol. 2021;142:109879.
    >> Share


    Graefes Arch Clin Exp Ophthalmol

  35. ERREN TC, Lewis P
    Secret hiding places in the eye and beyond: what about after SARS-CoV-2 infection?
    Graefes Arch Clin Exp Ophthalmol. 2021 Aug 3. pii: 10.1007/s00417-021-05323.
    >> Share


    Infect Control Hosp Epidemiol

  36. SCHWARTZ KL, Muller MP, Williams V, Harry R, et al
    COVID-19 risk among healthcare workers performing nasopharyngeal testing.
    Infect Control Hosp Epidemiol. 2021 Aug 2:1-7. doi: 10.1017/ice.2021.
    >> Share

  37. LEWIS SS, Kalu IC, Seidelman J, Anderson DJ, et al
    Challenges in Hospital-Acquired COVID-19 Surveillance and Attribution of Infection Source.
    Infect Control Hosp Epidemiol. 2021 Aug 2:1-11. doi: 10.1017/ice.2021.
    >> Share

  38. MELETIS G, Gkeka I, Tychala A, Fyntanidou B, et al
    Laboratory evaluation of the Abbott ID NOW rapid SARS-CoV-2 amplification assay and its potential use in the emergency department.
    Infect Control Hosp Epidemiol. 2021 Aug 2:1-5. doi: 10.1017/ice.2021.
    >> Share

  39. NOWROOZI A, Rezaei N
    SARS-CoV-2 delta variant of concern breakthrough infections: Are vaccines failing us?
    Infect Control Hosp Epidemiol. 2021 Aug 6:1-4. doi: 10.1017/ice.2021.
    >> Share

  40. SCHULZ-STUBNER S, Elke P
    Transmission of SARS CoV2 among health careworkers (HCW) during three waves of the SARS-CoV 2 pandemic in Germany: Results of an anonymous survey.
    Infect Control Hosp Epidemiol. 2021 Aug 2:1-7. doi: 10.1017/ice.2021.
    >> Share

  41. WEE LE, Conceicao EP, Aung MK, Oo AM, et al
    Rostered routine testing for healthcare workers and universal inpatient screening: the role of expanded hospital surveillance during an outbreak of COVID-19 in the surrounding community.
    Infect Control Hosp Epidemiol. 2021 Aug 6:1-9. doi: 10.1017/ice.2021.
    >> Share

  42. JAMAL SA, Farooq MU, Bidari V
    Challenges associated with using Core Threshold (Ct) value of RT-PCR as a criteria for infectiousness of Covid-19 patients in India.
    Infect Control Hosp Epidemiol. 2021 Aug 2:1-6. doi: 10.1017/ice.2021.
    >> Share

  43. LIANG Q, Sun C, Liu H, Zhang X, et al
    Vaccination Remains the First Choice to Control the Spread of Delta and Other Variants of SARS-CoV-2.
    Infect Control Hosp Epidemiol. 2021 Aug 6:1-4. doi: 10.1017/ice.2021.
    >> Share

  44. MOORE SE, Wilde AM, Bohn BC, Song M, et al
    Antimicrobial Stewardship in Patients with Confirmed COVID-19.
    Infect Control Hosp Epidemiol. 2021 Aug 2:1-9. doi: 10.1017/ice.2021.
    >> Share

  45. RIVERA F, Huerta S, Ahn KW, Munoz-Price LS, et al
    Incidence rate of SARS-CoV-2 among nurses in COVID-19 units vs. non-COVID-19-units at a large academic medical center.
    Infect Control Hosp Epidemiol. 2021 Aug 2:1-7. doi: 10.1017/ice.2021.
    >> Share

  46. HARITA S, Hamaguchi J, Shimizu K, Honda H, et al
    Respiratory extracorporeal membrane oxygenation and central-line-associated bloodstream infection: Experience at a tertiary-care center during the coronavirus disease 2019 (COVID-19) pandemic.
    Infect Control Hosp Epidemiol. 2021 Aug 2:1-3. doi: 10.1017/ice.2021.
    >> Share

  47. APISARNTHANARAK A, Nantapisal S, Pienthong T, Apisarnthanarak P, et al
    Healthcare-associated Transmission of COVID-19 Among Thai Healthcare Personnel Who Receive 2 Doses of a COVID-19 Vaccine: A Call for Considering a Booster Dose.
    Infect Control Hosp Epidemiol. 2021 Aug 6:1-9. doi: 10.1017/ice.2021.
    >> Share

  48. HENDERSON DK, Haessler S, Weber DJ
    The coronavirus disease 2019 (COVID-19) pandemic-Looking back and looking forward.
    Infect Control Hosp Epidemiol. 2021 Aug 2:1-6. doi: 10.1017/ice.2021.
    >> Share


    Int J Infect Dis

  49. YARANAGULA SD, Koduri VKC
    DimachkieSpectrum of Acute Neuropathy Associated with Covid-19: Clinical and electrophysiological study of 13 patients from a single center.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00621.
    >> Share

  50. QUACH HL, Nguyen KC, Hoang NA, Pham TQ, et al
    Association of public health interventions and COVID-19 incidence in Vietnam, January to December 2020.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00600.
    >> Share

  51. CLARO F, Silva D, Rodriguez M, Rangel R, et al
    IgG Antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals might need just one vaccine dose.
    Int J Infect Dis. 2021 Jul 31. pii: S1201-9712(21)00626.
    >> Share

  52. CHAU NVV, Nhan LNT, Nguyet LA, Tu NTK, et al
    Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam.
    Int J Infect Dis. 2021 Jul 30. pii: S1201-9712(21)00629.
    >> Share

  53. PATINO LH, Ballesteros N, Munoz M, Castaneda S, et al
    SARS-CoV-2 in transit: characterization of SARS-CoV-2 genomes from Venezuelan migrants in Colombia.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00624.
    >> Share

  54. AMIR M, Yoseph H, Farisi ATA, Phie JKP, et al
    Symptomatic Bradycardia in Covid-19 Hospitalized Patients: a Case Series.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00625.
    >> Share

  55. CHEN YH, Fang CT, Huang YL
    Effect of Non-lockdown Social Distancing and Testing-Contact Tracing During a COVID-19 Outbreak in Daegu, South Korea, February to April 2020: A Modeling Study.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00614.
    >> Share

  56. VELASQUEZ SR, Jacques L, Dalal J, Sestito P, et al
    The toll of COVID-19 on African children: A descriptive analysis on the COVID-19-related morbidity and mortality among the pediatric population in Sub-Saharan Africa.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00616.
    >> Share

  57. PERKMANN T, Perkmann-Nagele N, Mucher P, Radakovics A, et al
    Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00620.
    >> Share

  58. PALOMBA E, Carrabba M, Zuglian G, Alagna L, et al
    Treatment of SARS-CoV-2 Relapse with Remdesivir and Neutralizing Antibodies Cocktail in a Patient with X-Linked Agammaglobulinemia.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00619.
    >> Share


    Intensive Care Med

  59. ROUZE A, Lemaitre E, Nseir S
    COVID-19-associated invasive pulmonary aspergillosis: high incidence or difficult diagnosis?
    Intensive Care Med. 2021 Aug 3. pii: 10.1007/s00134-021-06499.
    >> Share


    J Infect

  60. BARBOSA GR, Moreira LVL, Justo AFO, Perosa AH, et al
    Rapid spread and high impact of the variant of concern P.1 in the largest city of Brazil.
    J Infect. 2021;83:119-145.
    >> Share

  61. FERNANDEZ-DE-LAS-PENAS C, Torres-Macho J, Velasco-Arribas M, Arias-Navalon JA, et al
    Similar prevalence of long-term post-COVID symptoms in patients with asthma: A case-control study.
    J Infect. 2021;83:237-279.
    >> Share

  62. MILLER E, Waight PA, Andrews NJ, McOwat K, et al
    Transmission of SARS-CoV-2 in the household setting: a prospective cohort study in children and adults in England.
    J Infect. 2021 Aug 1. pii: S0163-4453(21)00380.
    >> Share

  63. LUMLEY SF, Constantinides B, Sanderson N, Rodger G, et al
    Epidemiological data and genome sequencing reveals that nosocomial transmission of SARS-CoV-2 is underestimated and mostly mediated by a small number of highly infectious individuals.
    J Infect. 2021 Jul 28. pii: S0163-4453(21)00377.
    >> Share

  64. BENE MC, Bittencourt MC, Chevallier P
    Post-SARS-CoV-2 vaccination specific antibody decrease : let's get the half-full glass perspective.
    J Infect. 2021 Jul 28. pii: S0163-4453(21)00370.
    >> Share

  65. FERNANDEZ-DE-LAS-PENAS C, Palacios-Cena D, Gomez-Mayordomo V, Rodriuez-Jimenez J, et al
    Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study.
    J Infect. 2021;83:237-279.
    >> Share


    J Med Virol

  66. CASSUTO NG, Gravier A, Colin M, Theillay A, et al
    Evaluation of a SARS-CoV-2 antigen-detecting rapid diagnostic test as a self-test: diagnostic performance and usability.
    J Med Virol. 2021 Jul 31. doi: 10.1002/jmv.27249.
    >> Share

  67. DESHPANDE K, Pt U, Kaduskar O, Vijay N, et al
    Performance assessment of seven SARS-CoV-2 IgG enzyme linked immunosorbent assays.
    J Med Virol. 2021 Jul 31. doi: 10.1002/jmv.27251.
    >> Share

  68. UNSALER S, Okan A, Tekin S, Hafiz AM, et al
    Comparison of nasopharyngeal swab and nasopharyngeal aspiration in adults for SARS-CoV-2 identification using reverse transcription-polymerase chain reaction.
    J Med Virol. 2021 Jul 31. doi: 10.1002/jmv.27250.
    >> Share

  69. WERFEL S, Jakob CEM, Borgmann S, Schneider J, et al
    Development and Validation of a Simplified Risk Score for the Prediction of Critical COVID-19 Illness in Newly Diagnosed Patients.
    J Med Virol. 2021 Jul 31. doi: 10.1002/jmv.27252.
    >> Share

  70. ABDULAH DM
    ABDULAHPrevalence and correlates of COVID-19 vaccine hesitancy in general public in Iraqi Kurdistan: A cross-sectional study.
    J Med Virol. 2021 Aug 4. doi: 10.1002/jmv.27255.
    >> Share

  71. GUAN Y, Chen C, Guo A, Wei J, et al
    Prolonged Symptom Onset to Admission Time is Associated with Severe Coronavirus Disease: A Meta combined Propensity-adjusted Analysis.
    J Med Virol. 2021 Aug 4. doi: 10.1002/jmv.27253.
    >> Share

  72. ESSAR MY, Kazmi SK, Hasan MM, Santos Costa ACD, et al
    The rampant use of cow-dung to treat COVID-19: Is India at the brink of a zoonotic disease outbreak?
    J Med Virol. 2021 Aug 5. doi: 10.1002/jmv.27258.
    >> Share

  73. QURESHI QH, Ashraf T, Rehman K, Khosa MK, et al
    Therapeutic interventions of remdesivir in diabetic and non-diabetic COVID-19 patients: A prospective observational study conducted on Pakistani population.
    J Med Virol. 2021 Aug 5. doi: 10.1002/jmv.27256.
    >> Share


    J Travel Med

  74. CHEN LH, Petersen E, Blumberg L, Piyaphanee W, et al
    COVID-19 health passes: Current status and prospects for a global approach.
    J Travel Med. 2021 Aug 3. pii: 6338088. doi: 10.1093.
    >> Share

  75. SAPKAL GN, Yadav PD, Sahay RR, Deshpande G, et al
    Neutralization of Delta variant with sera of Covishield vaccinees and COVID-19 recovered vaccinated individuals.
    J Travel Med. 2021 Aug 3. pii: 6338089. doi: 10.1093.
    >> Share

  76. TSUCHIHASHI Y, Yamagishi T, Suzuki M, Sekizuka T, et al
    High attack rate of SARS-CoV-2 infections during a bus tour in Japan.
    J Travel Med. 2021 Jul 23. pii: 6326851. doi: 10.1093.
    >> Share


    JAMA

  77. DIAZ GA, Parsons GT, Gering SK, Meier AR, et al
    Myocarditis and Pericarditis After Vaccination for COVID-19.
    JAMA. 2021 Aug 4. pii: 2782900. doi: 10.1001/jama.2021.13443.
    >> Share


    Lancet

  78. THE LANCET
    Health in the USA: under examination and under repair.
    Lancet. 2021;397:641.
    >> Share

  79. DAS P
    Sharrelle Barber: at the intersection of place, race, and health.
    Lancet. 2021;397:659.
    >> Share

  80. MMONU NA, Aifah A, Onakomaiya D, Ogedegbe G, et al
    Why the global health community should support the EndSARS movement in Nigeria.
    Lancet. 2021;397:666-667.
    >> Share

  81. MAFHAM M, Baigent C
    What is the association of COVID-19 with heart attacks and strokes?
    Lancet. 2021 Jul 29. pii: S0140-6736(21)01071.
    >> Share

  82. LURIE N, Keusch GT, Dzau VJ
    Should global financing be the main priority for pandemic preparedness? - Authors' reply.
    Lancet. 2021;398:388-389.
    >> Share

  83. KATSOULARIS I, Fonseca-Rodriguez O, Farrington P, Lindmark K, et al
    Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study.
    Lancet. 2021 Jul 29. pii: S0140-6736(21)00896.
    >> Share

  84. PAN D, Martin CA, Nazareth J, Nevill CR, et al
    Ethnic disparities in COVID-19: increased risk of infection or severe disease?
    Lancet. 2021;398:389-390.
    >> Share

  85. MATHUR R, Rentsch CT, Morton CE, Eggo RM, et al
    Ethnic disparities in COVID-19: increased risk of infection or severe disease? - Authors' reply.
    Lancet. 2021;398:390.
    >> Share

  86. KAMPMANN B, Okomo U
    COVID-19 vaccines for children in LMICs: another equity issue.
    Lancet. 2021 Jul 30. pii: S0140-6736(21)01748.
    >> Share


    Lancet Infect Dis

  87. BALAKRISHNAN VS
    Impact of COVID-19 on migrants and refugees.
    Lancet Infect Dis. 2021;21:1076-1077.
    >> Share

  88. CHEN PZ, Koopmans M, Fisman DN, Gu FX, et al
    Understanding why superspreading drives the COVID-19 pandemic but not the H1N1 pandemic.
    Lancet Infect Dis. 2021 Aug 2. pii: S1473-3099(21)00406.
    >> Share

  89. TENBUSCH M, Schumacher S, Vogel E, Priller A, et al
    Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2.
    Lancet Infect Dis. 2021 Jul 29. pii: S1473-3099(21)00420.
    >> Share

  90. ESSO L, Epee E, Bilounga C, Abah A, et al
    Cameroon's bold response to the COVID-19 pandemic during the first and second waves.
    Lancet Infect Dis. 2021;21:1064-1065.
    >> Share

  91. LONG CM, Marzi A
    Biodefence research two decades on: worth the investment?
    Lancet Infect Dis. 2021;21:e222-e233.
    >> Share


    MMWR Morb Mortal Wkly Rep

  92. BROWN CM, Vostok J, Johnson H, Burns M, et al
    Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings - Barnstable County, Massachusetts, July 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1059-1062.
    >> Share

  93. HAUSE AM, Gee J, Baggs J, Abara WE, et al
    COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1053-1058.
    >> Share


    N Engl J Med

  94. GOLIGHER EC, Bradbury CA, McVerry BJ, Lawler PR, et al
    Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
    N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2103417.
    >> Share

  95. O'BRIEN MP, Forleo-Neto E, Musser BJ, Isa F, et al
    Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
    N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2109682.
    >> Share

  96. MOON S, Alonso Ruiz A, Vieira M
    Averting Future Vaccine Injustice.
    N Engl J Med. 2021;385:193-196.
    >> Share

  97. TEN CATE H
    Surviving Covid-19 with Heparin?
    N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMe2111151.
    >> Share

  98. COREY L, Beyrer C, Cohen MS, Michael NL, et al
    SARS-CoV-2 Variants in Patients with Immunosuppression.
    N Engl J Med. 2021;385:562-566.
    >> Share

  99. LAWLER PR, Goligher EC, Berger JS, Neal MD, et al
    Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
    N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2105911.
    >> Share


    Nature

  100. ELSE H
    COVID 'Fast Grants' sped up pandemic science.
    Nature. 2021 Aug 3. pii: 10.1038/d41586-021-02111.
    >> Share

  101. MALLAPATY S
    The COVID vaccine pioneer behind southeast Asia's first mRNA shot.
    Nature. 2021;594:163.
    >> Share

  102. DORAN M
    We need to talk about post-pandemic lectures.
    Nature. 2021 Jul 30. pii: 10.1038/d41586-021-02112.
    >> Share

  103. MAXMEN A
    COVID boosters for wealthy nations spark outrage.
    Nature. 2021 Jul 30. pii: 10.1038/d41586-021-02109.
    >> Share

  104. DAI H, Saccardo S, Han MA, Roh L, et al
    Behavioral Nudges Increase COVID-19 Vaccinations.
    Nature. 2021 Aug 2. pii: 10.1038/s41586-021-03843.
    >> Share

  105. MALLAPATY S
    The coronavirus is rife in common US deer.
    Nature. 2021 Aug 2. pii: 10.1038/d41586-021-02110.
    >> Share

  106. ROSEN J
    Pandemic upheaval offers a huge natural experiment.
    Nature. 2021;596:149-151.
    >> Share

  107. PATEL MS
    Text-message nudges encourage COVID vaccination.
    Nature. 2021 Aug 2. pii: 10.1038/d41586-021-02043.
    >> Share

  108. REARDON S
    Flawed ivermectin preprint highlights challenges of COVID drug studies.
    Nature. 2021 Aug 2. pii: 10.1038/d41586-021-02081.
    >> Share

  109. MALLAPATY S
    Delta threatens rural regions that dodged earlier COVID waves.
    Nature. 2021 Aug 6. pii: 10.1038/d41586-021-02146.
    >> Share

  110. CALLAWAY E
    COVID vaccine boosters: the most important questions.
    Nature. 2021 Aug 5. pii: 10.1038/d41586-021-02158.
    >> Share

  111. AREZKI R
    Cash payments in Africa could boost vaccine uptake.
    Nature. 2021;596:9.
    >> Share

  112. BALL P
    Surprise dip in UK COVID cases baffles researchers.
    Nature. 2021 Aug 3. pii: 10.1038/d41586-021-02125.
    >> Share

  113. COMBES AJ, Courau T, Kuhn NF, Hu KH, et al
    Publisher Correction: Global absence and targeting of protective immune states in severe COVID-19.
    Nature. 2021 Aug 2. pii: 10.1038/s41586-021-03718.
    >> Share

  114. DE GASPARO R, Pedotti M, Simonelli L, Nickl P, et al
    Publisher Correction: Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice.
    Nature. 2021 Aug 3. pii: 10.1038/s41586-021-03719.
    >> Share

  115. KOZLOV M
    A simple text has the power to increase COVID vaccinations.
    Nature. 2021 Aug 2. pii: 10.1038/d41586-021-02108.
    >> Share


    Radiology

  116. ISAAK A, Feisst A, Luetkens JA
    Myocarditis Following COVID-19 Vaccination.
    Radiology. 2021 Aug 3:211766. doi: 10.1148/radiol.2021211766.
    >> Share


    Science

  117. ALWAN NA
    The road to addressing Long Covid.
    Science. 2021;373:491-493.
    >> Share

  118. WADMAN M
    The overlooked superpower of mRNA vaccines.
    Science. 2021;373:479.
    >> Share

  119. PINTO D, Sauer MM, Czudnochowski N, Low JS, et al
    Broad betacoronavirus neutralization by a stem helix-specific human antibody.
    Science. 2021 Aug 3. pii: science.abj3321. doi: 10.1126/science.abj3321.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016